The immune system is an important mechanism for the human body to defend against foreign pathogens. It has the ability to identify enemies and friends, and will attack and eliminate "invaders". However, since cancer cells are derived from the body's own cells, they are autologous cells and can escape the recognition of the immune system.

The new generation of cellular immunotherapy based on iNKT cells has shown good anti-tumor potential and is one of the cutting-edge research directions in anti-tumor therapy. It is expected to safely and effectively inhibit the deterioration, recurrence and metastasis of cancer and meet the urgent treatment needs in the field of solid tumors.

With the continuous advancement of medical technology, the treatment methods for primary liver cancer are changing with each passing day. There are not only local treatment methods such as surgical resection/transplantation, ablation therapy, radiotherapy and chemotherapy, TACE/HAIC, but also targeted therapy, immunotherapy, traditional Chinese medicine treatment, and other systemic treatment methods. However, despite this, the overall long-term survival and cure effect of cancer patients in my country is still not ideal, especially for liver cancer.

The third generation of super immunotherapy, iNKT